Fintel · Sep 9, 2026
DO
NYSE · DOCS
Doximity, Inc.
Healthcare · Medical - Healthcare Information Services
$25.81
Down-$0.58 (-2.18%)
Updated Sep 16, 2026, 12:51 PM
SID Score
4.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 8.28B
- P/E ratio
- 32.73
- Dividend yield
- 0.00%
- 52-week range
- $17.15 – $76.51
- Volume
- 2.56M
- Avg. volume
- 1.87M
Price performance
DOCS price history
1M range · 20 trading sessions · Daily adjusted prices
DOCS closed at $25.81 after 20 trading sessions, up 3.49% for the selected period.
- Last close
- $25.81
- Period change
- +3.49%
- Period low
- $24.19
- Period high
- $27.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $26.02 | $26.825 | $25.57 | $25.81 | 2.56M |
| Sep 14, 2026 | $26.37 | $26.72 | $25.81 | $26.39 | 2.41M |
| Sep 11, 2026 | $24.70 | $25.73 | $24.70 | $25.58 | 2.7M |
| Sep 10, 2026 | $24.10 | $25.035 | $24.07 | $24.71 | 3.18M |
| Sep 9, 2026 | $24.36 | $24.57 | $23.955 | $24.19 | 2.62M |
| Sep 8, 2026 | $25.64 | $25.67 | $24.36 | $24.42 | 3.18M |
| Sep 4, 2026 | $26.77 | $27.03 | $26.31 | $26.35 | 1.98M |
| Sep 3, 2026 | $26.70 | $27.32 | $26.495 | $27.10 | 2.52M |
| Sep 2, 2026 | $26.26 | $27.00 | $26.20 | $26.32 | 1.98M |
| Sep 1, 2026 | $26.33 | $27.03 | $26.21 | $26.35 | 2.03M |
| Aug 31, 2026 | $25.84 | $26.846 | $25.84 | $26.71 | 2.19M |
| Aug 28, 2026 | $25.61 | $26.8683 | $25.33 | $26.73 | 3.29M |
| Aug 27, 2026 | $25.13 | $25.81 | $24.89 | $25.59 | 2.47M |
| Aug 26, 2026 | $24.50 | $25.195 | $24.4812 | $24.74 | 1.89M |
| Aug 25, 2026 | $24.95 | $25.35 | $24.60 | $24.74 | 1.73M |
| Aug 24, 2026 | $25.34 | $26.0829 | $25.10 | $25.30 | 2.87M |
| Aug 21, 2026 | $25.84 | $25.87 | $25.12 | $25.33 | 2.68M |
| Aug 20, 2026 | $25.63 | $26.46 | $25.18 | $25.94 | 2.56M |
| Aug 19, 2026 | $24.95 | $25.915 | $24.81 | $25.75 | 4.9M |
| Aug 18, 2026 | $24.94 | $25.28 | $24.745 | $24.94 | 2.98M |
Latest DOCS news
The latest Smart Investors Daily articles mentioning DOCS.
Stock researchCompany · Overview
DOCS research
Overview
Company profile and research snapshot.
Company profile
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $71.67
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 8, 2026 | Freedom Capital Markets | Hold | — |
| Aug 21, 2026 | Barclays | Equal-Weight | — |
| Aug 13, 2026 | Truist Securities | Hold | — |
| Aug 10, 2026 | Wells Fargo | Underweight | — |
| Aug 7, 2026 | Piper Sandler | Overweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 8, 2026
Freedom Capital Markets Downgrades Doximity to Hold, Raises Price Target to $27
Freedom Capital Markets analyst Gene Mannheimer downgrades Doximity (NYSE:DOCS) from Buy to Hold and raises the price target from $24 to $27.
ChartMill · Sep 2, 2026
Doximity (NYSE:DOCS): A Quality Investment with Superior Returns on Capital
Doximity (DOCS) excels as a quality stock: 125% ROIC, no debt, strong cash conversion. See why its fundamentals appeal to long-term investors.
Yahoo · Sep 1, 2026
3 Reasons to Avoid DOCS and 1 Stock to Buy Instead
Since March 2026, Doximity has been in a holding pattern, posting a small return of 2.8% while floating around $26.41. The stock also fell short of the S&P 500’s 12.1% gain during that period.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
